Beyond Conventional Therapy? Real-World Outcomes of Simultaneous Transcatheter Left Atrial Appendage and Congenital Atrial Septal Defect Closure

Abstract Objectives To evaluate the safety and efficacy of simultaneous transcatheter left atrial appendage (LAA) and atrial septal defect (ASD) closure versus ASD closure alone in a real-world cohort of patients with concurrent ASD and atrial fibrillation (AF). Methods Between January 2016 and June 2026, 289 ASD and AF patients were assigned to simultaneous LAA and ASD closure or the conventional ASD closure alone group based on clinical decision-making and anatomical suitability. To reduce potential confounding bias between groups, propensity score matching (PSM) was performed using 1:1 nearest-neighbor matching. The perioperative, 30 d, 90 d, and 180 d safety and efficacy of the two groups were assessed, and then the embolism, bleeding, and other complications were recorded at outpatient telephone visits every year, and the results of the follow-up. Results A total of 79 ASD with AF patients were included in the simultaneous occlusion group, of whom 27 received LACBES and 52 received LAmbre LAA occluders, while 79 ASD with AF patients who underwent ASD closure alone were matched by PSM. In the simultaneous occlusion group, three patients developed cardiac tamponade at 8, 20, and 30 h after occlusion, respectively. During follow-up, the simultaneous occlusion group had a lower incidence of bleeding events (2.53% vs. 13.92%, P = 0.017). No statistically significant difference was observed in the incidence of embolism events between the two groups (5.06% vs. 15.19%, P = 0.062). Compared with ASD closure alone, simultaneous LAA + ASD occlusion was associated with a lower risk of all thromboembolic events (HR = 0.333, 95% CI: 0.125–0.888, P = 0.0455) and a significantly lower risk of bleeding events (HR = 0.182, 95% CI: 0.061–0.539, P = 0.0126). Conclusion In this real-world observational cohort, simultaneous percutaneous LAA and ASD closure in carefully selected patients was associated with favorable long-term safety and effectiveness, particularly in reducing thromboembolic events and bleeding events risk compared with ASD closure alone.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11285918/v1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beyond Conventional Therapy? Real-World Outcomes of Simultaneous Transcatheter Left Atrial Appendage and Congenital Atrial Septal Defect Closure

涂丁元, Meng Zhang, Qiguang Wang, Yutang Li et al.
2 links
Research Square
Atrial Fibrillation Management and Outcomes
preprint

Beyond Conventional Therapy? Real-World Outcomes of Simultaneous Transcatheter Left Atrial Appendage and Congenital Atrial Septal Defect Closure

涂丁元, Meng Zhang, Qiguang Wang, Yutang Li, Jianming Wang, Yujuan Wang, Yuan Mi, Jiawang Xiao, Jingsong Geng
preprint en

Abstract

Abstract Objectives To evaluate the safety and efficacy of simultaneous transcatheter left atrial appendage (LAA) and atrial septal defect (ASD) closure versus ASD closure alone in a real-world cohort of patients with concurrent ASD and atrial fibrillation (AF). Methods Between January 2016 and June 2026, 289 ASD and AF patients were assigned to simultaneous LAA and ASD closure or the conventional ASD closure alone group based on clinical decision-making and anatomical suitability. To reduce potential confounding bias between groups, propensity score matching (PSM) was performed using 1:1 nearest-neighbor matching. The perioperative, 30 d, 90 d, and 180 d safety and efficacy of the two groups were assessed, and then the embolism, bleeding, and other complications were recorded at outpatient telephone visits every year, and the results of the follow-up. Results A total of 79 ASD with AF patients were included in the simultaneous occlusion group, of whom 27 received LACBES and 52 received LAmbre LAA occluders, while 79 ASD with AF patients who underwent ASD closure alone were matched by PSM. In the simultaneous occlusion group, three patients developed cardiac tamponade at 8, 20, and 30 h after occlusion, respectively. During follow-up, the simultaneous occlusion group had a lower incidence of bleeding events (2.53% vs. 13.92%, P = 0.017). No statistically significant difference was observed in the incidence of embolism events between the two groups (5.06% vs. 15.19%, P = 0.062). Compared with ASD closure alone, simultaneous LAA + ASD occlusion was associated with a lower risk of all thromboembolic events (HR = 0.333, 95% CI: 0.125–0.888, P = 0.0455) and a significantly lower risk of bleeding events (HR = 0.182, 95% CI: 0.061–0.539, P = 0.0126). Conclusion In this real-world observational cohort, simultaneous percutaneous LAA and ASD closure in carefully selected patients was associated with favorable long-term safety and effectiveness, particularly in reducing thromboembolic events and bleeding events risk compared with ASD closure alone.

Research Square
Chinese People's Liberation Army (CN)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon